John P Kirwan1,2, Steven K Malin3, Amanda R Scelsi3, Emily L Kullman3, Sankar D Navaneethan4, Mangesh R Pagadala2, Jacob M Haus3, Julianne Filion3, Jean-Philippe Godin5, Sunil Kochhar5, Alastair B Ross5,6. 1. Department of Pathobiology, Lerner Research Institute, kirwanj@ccf.org. 2. Department of Gastroenterology and Hepatology, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH. 3. Department of Pathobiology, Lerner Research Institute. 4. Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, and. 5. Analytical Sciences Department, Nestlé Research Center, Lausanne, Switzerland; and. 6. Division of Food and Nutrition Science, Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenberg, Sweden.
Abstract
BACKGROUND: Increased dietary whole-grain intake may protect against cardiovascular disease (CVD). OBJECTIVE: The objective was to evaluate the efficacy of whole grains compared with refined grains on body composition, hypertension, and related mediators of CVD in overweight and obese adults. METHODS: We conducted a double-blind, randomized, controlled crossover trial in 40 overweight or obese men and women aged <50 y with no known history of CVD. Complete whole-grain and refined-grain diets were provided for two 8-wk periods, with a 10-wk washout between diets. Macronutrient composition was matched, except for the inclusion of either whole grains or refined grains (50 g/1000 kcal in each diet). Measurements included blood pressure, body composition, blood lipids and adiponectin, and markers of inflammation and glycemia. RESULTS:Thirty-three participants (6 men and 27 women) completed the trial [mean ± SD age: 39 ± 7 y; mean ± SD body mass index (in kg/m2): 33.1 ± 4.3]. Decreases in diastolic blood pressure were -5.8 mm Hg (95% CI: -7.7, -4.0 mm Hg) after the whole-grain diet and -1.6 mm Hg (95% CI: -4.4, 1.3 mm Hg) after the control diet (between effect, P = 0.01). Decreases in plasma adiponectin were -0.1 (95% CI: -0.9, 0.7) after the whole-grain diet and -1.4 (95% CI: -2.6, -0.3) after the control diet (between effect, P = 0.05). Decreases in diastolic blood pressure correlated with the circulating adiponectin concentration (r = 0.35, P = 0.04). Substantial reductions in body weight, fat loss, systolic blood pressure, total cholesterol, and LDL cholesterol were observed during both diet periods, with no relevant difference between them. CONCLUSIONS: The improvement in diastolic blood pressure was >3-fold greater in overweight and obese adults when they consumed a whole-grain compared with a refined-grain diet. Because diastolic blood pressure predicts mortality in adults aged <50 y, increased whole-grain intake may provide a functional approach to control hypertension. This may benefit patients at risk of vascular-related morbidity and mortality. This trial was registered at clinicaltrials.gov as NCT01411540.
RCT Entities:
BACKGROUND: Increased dietary whole-grain intake may protect against cardiovascular disease (CVD). OBJECTIVE: The objective was to evaluate the efficacy of whole grains compared with refined grains on body composition, hypertension, and related mediators of CVD in overweight and obese adults. METHODS: We conducted a double-blind, randomized, controlled crossover trial in 40 overweight or obesemen and women aged <50 y with no known history of CVD. Complete whole-grain and refined-grain diets were provided for two 8-wk periods, with a 10-wk washout between diets. Macronutrient composition was matched, except for the inclusion of either whole grains or refined grains (50 g/1000 kcal in each diet). Measurements included blood pressure, body composition, blood lipids and adiponectin, and markers of inflammation and glycemia. RESULTS: Thirty-three participants (6 men and 27 women) completed the trial [mean ± SD age: 39 ± 7 y; mean ± SD body mass index (in kg/m2): 33.1 ± 4.3]. Decreases in diastolic blood pressure were -5.8 mm Hg (95% CI: -7.7, -4.0 mm Hg) after the whole-grain diet and -1.6 mm Hg (95% CI: -4.4, 1.3 mm Hg) after the control diet (between effect, P = 0.01). Decreases in plasma adiponectin were -0.1 (95% CI: -0.9, 0.7) after the whole-grain diet and -1.4 (95% CI: -2.6, -0.3) after the control diet (between effect, P = 0.05). Decreases in diastolic blood pressure correlated with the circulating adiponectin concentration (r = 0.35, P = 0.04). Substantial reductions in body weight, fat loss, systolic blood pressure, total cholesterol, and LDL cholesterol were observed during both diet periods, with no relevant difference between them. CONCLUSIONS: The improvement in diastolic blood pressure was >3-fold greater in overweight and obese adults when they consumed a whole-grain compared with a refined-grain diet. Because diastolic blood pressure predicts mortality in adults aged <50 y, increased whole-grain intake may provide a functional approach to control hypertension. This may benefit patients at risk of vascular-related morbidity and mortality. This trial was registered at clinicaltrials.gov as NCT01411540.
Authors: Thomas Pj Solomon; Jacob M Haus; Karen R Kelly; Marc D Cook; Julianne Filion; Michael Rocco; Sangeeta R Kashyap; Richard M Watanabe; Hope Barkoukis; John P Kirwan Journal: Am J Clin Nutr Date: 2010-10-27 Impact factor: 7.045
Authors: Hongyu Wu; Alan J Flint; Qibin Qi; Rob M van Dam; Laura A Sampson; Eric B Rimm; Michelle D Holmes; Walter C Willett; Frank B Hu; Qi Sun Journal: JAMA Intern Med Date: 2015-03 Impact factor: 21.873
Authors: Steven K Malin; Emily L Kullman; Amanda R Scelsi; Jacob M Haus; Julianne Filion; Mangesh R Pagadala; Jean-Philippe Godin; Sunil Kochhar; Alastair B Ross; John P Kirwan Journal: Metabolism Date: 2018-01-03 Impact factor: 8.694
Authors: Steven K Malin; Emily L Kullman; Amanda R Scelsi; Jean-Philippe Godin; Alastair B Ross; John P Kirwan Journal: Mol Nutr Food Res Date: 2019-03-20 Impact factor: 5.914
Authors: Huicui Meng; Nirupa R Matthan; Susan K Fried; Silvia Berciano; Maura E Walker; Jean M Galluccio; Alice H Lichtenstein Journal: J Clin Endocrinol Metab Date: 2018-09-01 Impact factor: 5.958
Authors: John P Kirwan; Christopher L Axelrod; Emily L Kullman; Steven K Malin; Wagner S Dantas; Kathryn Pergola; Juan Pablo Del Rincon; Stacy A Brethauer; Sangeeta R Kashyap; Philip R Schauer Journal: J Clin Endocrinol Metab Date: 2021-09-27 Impact factor: 5.958
Authors: Sarah Am Kelly; Louise Hartley; Emma Loveman; Jill L Colquitt; Helen M Jones; Lena Al-Khudairy; Christine Clar; Roberta Germanò; Hannah R Lunn; Gary Frost; Karen Rees Journal: Cochrane Database Syst Rev Date: 2017-08-24